NexGelNXGL
About: NexGel Inc manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The gels and consumer products are manufactured using proprietary and non-proprietary mixing, coating, and cross-linking technologies.
Employees: 19
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
200% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 2
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
71% more capital invested
Capital invested by funds: $346K [Q2] → $590K (+$244K) [Q3]
9% more funds holding
Funds holding: 11 [Q2] → 12 (+1) [Q3]
0.81% more ownership
Funds ownership: 2.57% [Q2] → 3.38% (+0.81%) [Q3]
Research analyst outlook
We haven’t received any recent analyst ratings for NXGL.
Financial journalist opinion
Based on 3 articles about NXGL published over the past 30 days